BMS Kidney Transplant Co-Pay Assistance Program: Nulojix

Funded
About
The BMS Kidney Transplant Co-Pay Assistance Program: Nulojix offers financial assistance to eligible patients who have commercial insurance but face high co-pay costs for the drug Nulojix. This program, exclusive to the United States and Puerto Rico, helps kidney transplant patients managing kidney rejection with BMS medications by covering co-pays up to $7,000 annually, making the treatment more accessible.
Insurance requirements: Commercially insured
As low as: $50 per fill
Enrollment Forms
Enrollment Form
Benefits
•$7000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Eligible commercially insured patients pay the first $50 for each outpatient dose of NULOJIX
•Program will cover the remainder of the copay, up to a maximum of $7,000 during a calendar year
•Patients are responsible for any costs that exceed the Program’s $7,000 maximum
•Program benefits are limited to the copay costs for BMS medications covered by this Program that the patient receives as an outpatient
•The Program will not cover the cost of any dosing procedure, any other healthcare provider service or supply charges or other treatment costs, or any costs associated with a hospital stay
•In order to receive the copay benefits, Patient or provider must submit an Explanation of Benefits (EOB) form within 180 days of receiving each dose of NULOJIX. The submitted form must include the name of the insurer, plan information, and show that the BMS medication supported by this program was the medication that was given
•Patient may be able to use the program to cover outpatient doses that occurred within 180 days prior to the date of enrollment
•Completed forms should be faxed to 8339582087